medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 3

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (3)

Clinical characteristics of Cuban patients infected with Zika virus

Veitía VAY, Duque VM, Gravier HR, González RD, Castro PO

Language: Spanish
References: 20
Page:
PDF size: 304.21 Kb.


ABSTRACT

Introduction: Zika is caused by the virus of the same name, an arbovirus transmitted mainly by the bite of the Aedes mosquito. The risk of reintroduction and autochthonous circulation of Zika virus in Cuba remains; therefore, it is considered a current problem.
Objective: To characterize the clinical behavior of Zika virus infection in patients admitted to the Institute of Tropical Medicine Pedro Kourí (IPK).
Methods: It was conducted a cross-sectional, descriptive study with an analytic component in patients with a diagnosis of Zika admitted to IPK from November 2016 to May 2017. Sociodemographic, clinical, biomedical and microbiological variables were analyzed.
Results: In patients confirmed with Zika virus, the main clinical manifestations (p≤ 0.05) were pruritus and adenomegaly; with significantly longer duration of rash. Regarding confirmation studies by real-time polymerase chain reaction, the urine sample had significantly higher positivity values than the serum samples from the onset of the clinical picture.
Conclusions: Pruritus and adenomegaly prevailed in the autochthonous cases of Zika under study. This allowed conducting a presumptive and differentiated diagnosis to other patients with a febrile syndrome. The microbiological diagnosis to confirm this arbovirus was performed by molecular methods. In the majority of cases, the urine samples were very useful from the first days after the onset of the symptoms.


REFERENCES

  1. DiNunno NM, Goetschius DJ, Narayanan A, Majowicz SA, Moustafa I, Bator CM, et al. Identification of a pocket factor that is critical to Zika virus assembly. Nature Communications. 2020;11(1):4953.

  2. Johargy A. Zika Virus Infection: A Global Health Emergency. Egyptian J Medical Microbiology. 2022;31(1):2537-79.

  3. PAHO/WHO. 2016: el año en que el Zika evolucionó de una emergencia a un desafío de salud pública a largo plazo. PAHO; 2017 [acceso 08/04/2019]. Disponible en: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=12861:2016-zika-evolved-from-emergency-into-long-term-public-health-challenge&Itemid=1926&lang=es3.

  4. PAHO/WHO. Zika-Epidemiological Report Cuba 2017. PAHO; 2017 [acceso 19/09/2020]. Disponible en: https://www.paho.org/hq/dmdocuments/2017/2017-phe-zika-situation-report-cub.pdf4.

  5. Song BH, Yun SI, Woolley M, Lee YM. Zika virus: History, epidemiology, transmission, and clinical presentation. Journal of Neuroimmunology. 2017;308:50-64.

  6. Pergolizzi J Jr., LeQuang JA, Umeda-Raffa S, Fleischer C, Pergolizzi J, Pergolizzi C, et al. The Zika virus: Lurking behind the COVID-19 pandemic? Journal of Clinical Pharmacy and Therapeutics. 2021;46(2):267-76.

  7. Menezes-Neto A, Castilho MDC, Calvet GA, Kara EO, Bôtto-Menezes CHA, Lacerda MVG, et al. Zika virus RNA excretion in sweat with concomitant detection in other body fluid specimens. Memorias do Instituto Oswaldo Cruz. 2021;115:e200339.

  8. Mendonça PD, Santos LKB, Foguel MV, Rodrigues MAB, Cordeiro MT, Gonçalves LM, et al. NS1 glycoprotein detection in serum and urine as an electrochemical screening immunosensor for dengue and Zika virus. Analytical and Bioanalytical Chemistry. 2021;413(19):4873-85.

  9. da Conceição PJP, de Carvalho LR, de Godoy BLV, Nogueira ML, Terzian ACB, de Godoy MF, et al. Detection of Zika virus in urine from randomly tested individuals in Mirassol, Brazil. Infection. 2022;50(1):149-56.

  10. Lazear HM, Diamond MS. Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. Journal of Virology. 2016;90(10):4864-75.

  11. Montaño-Mendoza V, Mendez-Cortina Y, Montoya C, Urcuqui-Inchima S, Velilla-Hernandez P, Cardona-Maya W. Implicaciones de los virus Zika y Chikungunya en el semen durante la transmisión sexual. Rev Cubana Med Tropical. 2022;74(1):e692.

  12. Guzmán M, Vázquez S, Álvarez M, Pelegrino J, Ruiz D, Martínez P, et al. Vigilancia de laboratorio de dengue y otros arbovirus en Cuba, 1970-2017. Rev Cubana Med Tropical. 2019;71(1):e338.

  13. OPS/OMS. Zika 2019. OPS; 2019 [acceso 16/12/2020]. Disponible en: http://www.paho.org/es/temas/zika13.

  14. Boggild AK, Geduld J, Libman M, Yansouni CP, McCarthy AE, Hajek J, et al. Surveillance report of Zika virus among Canadian travellers returning from the Americas. CMAJ: Canadian Med Assoc J. 2017;189(9):E334-E40.

  15. Cerbino-Neto J, Mesquita EC, Souza TM, Parreira V, Wittlin BB, Durovni B, et al. Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015. Emerging Infectious Diseases. 2016;22(7):1318-20.

  16. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K. First report of autochthonous transmission of Zika virus in Brazil. Memorias do Instituto Oswaldo Cruz. 2015;110(4):569-72.

  17. PAHO/OMS. Instrumento para el diagnóstico y la atención a pacientes con sospecha de arbovirosis 2016. PAHO; 2017 [acceso 08/04/2019]. Disponible en: https://iris.paho.org/handle/10665.2/3144817.

  18. Brasil P, Calvet GA, Siqueira AM, Wakimoto M, de Sequeira PC, Nobre A, et al. Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological Aspects. PLoS Neglected Tropical Diseases. 2016;10(4):e0004636.

  19. Campos R de M, Cirne-Santos C, Meira GL, Santos LL, de Meneses MD, Friedrich J, et al. Prolonged detection of Zika virus RNA in urine samples during the ongoing Zika virus epidemic in Brazil. J Clinical Virology: the official publication of the Pan American Society for Clinical Virology. 2016;77:69-70.

  20. Almuedo-Riera A, Rodriguez-Valero N, Camprubí D, Losada Galván I, Zamora-Martinez C, Pousibet-Puerto J, et al. Mirroring the Zika epidemics in Cuba: The view from a European imported diseases clinic. Travel Medicine And Infectious Disease. 2019;30:125-7.




2020     |     www.medigraphic.com